Irreversible inhibition of Δ16HER2 is necessary to suppress Δ16HER2-positive breast carcinomas resistant to Lapatinib.
about
β-lapachone suppresses tumour progression by inhibiting epithelial-to-mesenchymal transition in NQO1-positive breast cancersResveratrol fuels HER2 and ERα-positive breast cancer behaving as proteasome inhibitor.HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic responseAlternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.
P2860
Irreversible inhibition of Δ16HER2 is necessary to suppress Δ16HER2-positive breast carcinomas resistant to Lapatinib.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Irreversible inhibition of Δ16 ...... inomas resistant to Lapatinib.
@en
type
label
Irreversible inhibition of Δ16 ...... inomas resistant to Lapatinib.
@en
prefLabel
Irreversible inhibition of Δ16 ...... inomas resistant to Lapatinib.
@en
P2093
P50
P1433
P1476
Irreversible inhibition of Δ16 ...... inomas resistant to Lapatinib.
@en
P2093
Albana Hysi
Augusto Amici
Caterina Bartolacci
Chiara Garulli
Cristina Kalogris
Cristina Marchini
Fiorenza Orlando
Junbiao Wang
Lucia Pietrella
Martina Tilio
P356
10.1016/J.CANLET.2016.07.028
P407
P50
P577
2016-07-27T00:00:00Z